Jun Chen

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Pulmonary Fibrosis

Dna Damage Response

Epithelial Mesenchymal Transition

Induced Apoptosis

Top Venues

Cell death & disease

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Guangsheng Zhu, Yanan Wang, Yingjie Wang, Hua Huang, Boshi Li, Peijie Chen, Chen Chen, Hongbing Zhang, Yongwen Li, Hongyu Liu, Jun Chen
Myofibroblasts derived type V collagen promoting tissue mechanical stress and facilitating metastasis and therapy resistance of lung adenocarcinoma cells. Cell death & disease 15 (7) (2024)
Guangsheng Zhu, Yanan Wang, Yingjie Wang, Hua Huang, Boshi Li, Peijie Chen, Chen Chen, Hongbing Zhang, Yongwen Li, Hongyu Liu, Jun Chen
Myofibroblasts derived type V collagen promoting tissue mechanical stress and facilitating metastasis and therapy resistance of lung adenocarcinoma cells. Cell death & disease 15 (7) (2024)
Zihe Zhang, Yongwen Li, Ruifeng Shi, Chaoyi Jia, Songlin Xu, Guangsheng Zhu, Peijun Cao, Hua Huang, Xuanguang Li, Hongbing Zhang, Minghui Liu, Chen Chen, Hongyu Liu, Chun-Sheng Kang, Jun Chen
L3MBTL1, a polycomb protein, promotes Osimertinib acquired resistance through epigenetic regulation of DNA damage response in lung adenocarcinoma. Cell death & disease 15 (9) (2024)
Guangsheng Zhu, Yanan Wang, Yingjie Wang, Hua Huang, Boshi Li, Peijie Chen, Chen Chen, Hongbing Zhang, Yongwen Li, Hongyu Liu, Jun Chen
Myofibroblasts derived type V collagen promoting tissue mechanical stress and facilitating metastasis and therapy resistance of lung adenocarcinoma cells. Cell death & disease 15 (7) (2024)
Guangsheng Zhu, Yanan Wang, Yingjie Wang, Hua Huang, Boshi Li, Peijie Chen, Chen Chen, Hongbing Zhang, Yongwen Li, Hongyu Liu, Jun Chen
Myofibroblasts derived type V collagen promoting tissue mechanical stress and facilitating metastasis and therapy resistance of lung adenocarcinoma cells. Cell death & disease 15 (7) (2024)
Minghui Liu, Xin Li, Hongbing Zhang, Fan Ren, Jinghao Liu, Yongwen Li, Ming Dong, Honglin Zhao, Song Xu, Hongyu Liu, Jun Chen
Apatinib added when NSCLC patients get slow progression with EGFR-TKI: A prospective, single-arm study. Cancer medicine (2023)